Telogen Effluvium and COVID-19: A Cross-Sectional Study

A cross-sectional study involving 561 participants from the Asir region of Saudi Arabia found a significant link between COVID-19 infection and increased incidence of Telogen Effluvium (TE), a type of non-scarring hair loss that occurs after a stressful event. The study found that 73.3% of participants experienced an increase in hair loss after COVID-19 infection. The incidence of TE was higher among females, with 77.3% of female participants experiencing increased hair loss post-infection compared to 43.3% of males. The study also found that awareness about TE was generally poor among participants, with only 10.9% having a good awareness level. The study concluded that COVID-19 infections are highly related to the incidence of TE, particularly among the female population.